Notably, it was found that the number of GFAP+ astrocytes decreased in hippocampus and cortex of CMS mice, while fluoxetine treatment attenuated the loss of astrocytes in CMS model (Fig. 1e). The gene discussed is GFAP; the disease is congenital myasthenic syndrome.